| Identification | Back Directory | [Name]
Prostaglandin E2-d9 | [CAS]
1356347-42-6 | [Synonyms]
Prostaglandin E2-d9
XEYBRNLFEZDVAW-GMIZMOFXSA-N | [Molecular Formula]
C20H23D9O5 | [MDL Number]
MFCD18428003 | [MOL File]
1356347-42-6.mol | [Molecular Weight]
361.521 |
| Hazard Information | Back Directory | [Description]
PGE2-d9 contains nine deuterium atoms at the 17, 17’, 18, 18’, 19, 19'', 20, 20, and 20'' positions. It is intended for use as an internal standard for the quantification of PGE2 by GC- or LC-mass spectrometry (MS). PGE2 is one of the primary cyclooxygenase products of arachidonic acid and one of the most widely investigated prostaglandins. Its activity influences inflammation, fertility and parturition, gastric mucosal integrity, and immune modulation. The effects of PGE2 are transduced by at least four distinct receptors designated EP1, EP2, EP3, and EP4. Affinity constants (Kd) of PGE2 for these receptors range from 1-10 nM depending on the receptor subtype and tissue. | [Uses]
Prostaglandin E2-d9 is the deuterium labeled Prostaglandin E2. Prostaglandin E2 (PGE2) is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation[1][2]. | [IC 50]
EP | [References]
[1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Chouaib S, et al. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes. J Immunol. 1984 Apr;132(4):1851-7. PMID:6230395
[3] Fernandez-Repollet E, et al. In vivo effects of prostaglandin E2 and arachidonic acid on phagocytosis of fluorescent methacrylate microbeads by rat peritoneal macrophages. J Histochem Cytochem. 1982 May;30(5):466-70. DOI:10.1177/30.5.6804558
[4] Haylor J, et al. Renal vasodilator activity of prostaglandin E2 in the rat anaesthetized with pentobarbitone. Br J Pharmacol. 1982 May;76(1):131-7. DOI:10.1111/j.1476-5381.1982.tb09198.x |
|
|